Navigation Links
JDRF Illinois Names Allscripts CEO Glen Tullman 'Best of Illinois' for His Efforts to Find a Cure for Type 1 Diabetes
Date:5/26/2009

CHICAGO, May 26 /PRNewswire/ -- The Juvenile Diabetes Research Foundation Illinois, the state chapter of the leading charitable funder and advocate of type 1 diabetes research worldwide, has named Glen Tullman, Chief Executive Officer of Allscripts (Nasdaq: MDRX), its "Best of Illinois" for his service on the Illinois Board of Directors, on the International Board, and for his support of the organization's efforts in developing an artificial pancreas.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO)

JDRF Illinois honored Mr. Tullman at its annual Best of Illinois dinner May 21. The event raised more than $1 million, including over $500,000 for the Artificial Pancreas Program. The development of an artificial pancreas, one of JDRF's top research priorities, would enable a person with diabetes to maintain normal glucose levels by continuously monitoring blood glucose levels and then providing an exact dose of insulin automatically through an integrated pump.

"I am honored to be recognized by JDRF Illinois, however the real reward will come only when we win the race to find a cure for diabetes once and for all," said Mr. Tullman, whose son and niece have type-1 diabetes. "I'm very optimistic that, through JDRF's cutting-edge research, which includes the Artificial Pancreas and other important breakthroughs, and the generosity of tens of thousands of supporters around the world, we will find a cure for this terrible disease, which millions of us confront in our own families every day."

Mr. Tullman is a longtime active supporter and advocate for JDRF and has contributed to raising millions of dollars in search of a cure, along with his family's own contributions, which are measured in the millions. He also has encouraged Allscripts, the leading provider of Electronic Health Records, to become a lead sponsor of JDRF volunteer fundraising events in Illinois, North Carolina, Vermont and other states where the company has offices.

"Glen Tullman is a passionate and selfless advocate of the JDRF cause who has worked to advance the cause for many years both through his volunteer activities and his many generous gifts to the Foundation," said Patrick Reedy, Executive Director of JDRF Illinois. "Glen not only is a visionary leader in his own business of transforming our healthcare system using technology, but one of the many extraordinary Illinois leaders who share a common interest in supporting cutting edge research and technology that will lead to a cure for type 1 diabetes."

ABOUT JUVENILE DIABETES RESEARCH FOUNDATION

The Juvenile Diabetes Research Foundation International was founded in 1970 by the parents of children with type 1 diabetes and is the world's largest charitable funder and advocate of type 1 diabetes research. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. JDRF provided more than $137 million to diabetes research in FY 2007, and is responsible for more than $1.16 billion in direct funding since it was founded. JDRF annually receives top rankings from independent sources that rate charitable giving. For more information please visit www.jdrf.org.


'/>"/>
SOURCE JDRF
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Passage of Illinois House Bill 2290 Adds Crucial Due Process Protection Governing Sterilization of Adults With Disabilities
2. Illinois Medical District Presented with "Good Neighbor Award"
3. ASG Business Development Team Expands in Illinois
4. Illinois Soybean Association to Participate in Global Child Nutrition Forum in South Africa
5. New Illinois Prosecution Unit Helps Protect Women Against Violence
6. 5th Anniversary Illinois Lions Clubs Walk for Sight
7. Illinois-Based AthletiCo Opens Milestone 50th Physical Therapy Center
8. 57 (More) Reasons to Buy a Contract From College Illinois!(SM)
9. Illinois Hospitals Hit Hard By Recession
10. The Healy Law Firm Represents Plaintiff in $12 Million Settlement with Clark USA Over Fatal Illinois Oil Refinery Accident
11. Illinois Lottery Releases New MS Ticket, Dash! For Cash
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... WV (PRWEB) , ... August 18, 2017 , ... ... financial consulting services and asset protection assistance to communities in North-Central West Virginia, ... provide critical services to at-risk boys in the area. , The Chestnut Mountain ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Brian Gifford Agency, an Indiana-based ... campaigning in support of Campagna Academy in a charity drive to provide for at-risk ... Town of Indiana,” Campagna Academy is a nonprofit organization that has offered critical programs ...
(Date:8/18/2017)... ... 2017 , ... “Emotions are sacred, valid, honored, encouraged. This is the memo ... Generation Mindful. To help change the mindset of parents and educators from punitive to ... the Time-In Toolkit, which launched on Kickstarter 3 weeks ago and fully funded in ...
(Date:8/18/2017)... ... , ... Alcovit, a lime-flavored beverage that rids the body of toxins linked ... now available through Jet.com. , After 25 years of development, the company released ... to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re having fun with ...
(Date:8/18/2017)... ... August 18, 2017 , ... “Our Mountains to Climb: A Journey ... couple that grew stronger together through the faith they shared to overcome struggles in ... the creation of published author, Barbara J. Corcoran, a retired teacher and happily married ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global ... Directors has approved the payment of a quarterly cash dividend ... The cash dividend of $0.24 per ... to stockholders of record as of the close of business ... to approval of the Board of Directors and may be ...
(Date:8/4/2017)... 3, 2017  Agragen, LLC, a ... the biopharmaceutical, nutraceutical, and aquacultural feed sectors, announces ... lead drug candidates, AGR131.  This drug is designed ... the blood of patients suffering from inflammatory conditions ... disease. Biological ...
(Date:8/2/2017)... -- CaryRx, a next-generation full-service pharmacy, has announced the launch ... the Washington D.C. metropolitan area. CaryRx ... of medications through the convenience of its patient-friendly mobile app. ... one hour to any location in D.C. ... service to Washington D.C. ," says Areo ...
Breaking Medicine Technology: